Reg 74(5) certificate from registrar for Q2 FY27 filed

Compliance View source PDF Explain this filing

ALPA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.5%Reaction day

₹58.30

prior close

₹56.90

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.7%-2.3% vs market

Pharmaceuticals peers, median of 172sector+0.0%-1.5% vs sector

On the reaction day the stock moved 2.3 pts less than Nifty Microcap 250 and 1.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.5+0.7-2.3+0.0-1.5

Next day

-4.3-1.0-3.3-0.8-3.5

-7.7-0.3-7.5-0.6-7.2

-11.2-1.9-9.3-1.9-9.4

-12.1-4.5-7.6-3.5-8.6

-11.7-5.5-6.2-4.4-7.3

-17.0-7.3-9.7-4.3-12.7

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Alpa Laboratories has submitted to BSE and NSE the quarterly certificate under SEBI Regulation 74(5) for the quarter ended 30 September 2026. The certificate, issued by Bigshare Services (Registrar and Share Transfer Agent), confirms that all securities received for dematerialisation were processed and the physical certificates were cancelled, with depository names updated in the register of members within 15 days.

Likely market impact

Routine compliance filing. No material effect on shareholders or stock price.